Overview
Xue Dong practices practicing medicine in Tianjin, China.
Their clinical expertise encompasses Diabetic Retinopathy, Retinal Detachment, Ganglion Cyst, Limb-Girdle Muscular Dystrophy, and Vitrectomy.
They are actively involved in clinical research, co-authoring 22 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xue Dong
Is Xue Dong a top-rated expert for Vitrectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Xue Dong is classified as an Experienced expert for Vitrectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xue Dong participate in research or clinical trials?
Yes. Xue Dong has published 22 articles and abstracts on conditions like Vitrectomy. You can view a list of Xue Dong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Diabetic RetinopathyDong isExperienced. Learn about Diabetic Retinopathy.
- Ganglion CystDong isExperienced. Learn about Ganglion Cyst.
- Limb-Girdle Muscular Dystrophy
- Retinal DetachmentDong isExperienced. Learn about Retinal Detachment.
- VitrectomyDong isExperienced. Learn about Vitrectomy.